By comparing the overexpressed genes in BC and the three genes associated with aspirin DPT in BC, we identified five genes GSK3B, CDC20, TPX2, AURKA and CCNE1 (Fig. 5; Table 5) as potential therapeutic targets of aspirin in BC. This evidence concerns the gene GSK3B and breast cancer.